Chen, Yu
Meng, Fanyan
Song, Fang
Tang, Cailin
Chen, Baolin
Zhao, Shihan
Ge, Zhuoqi
Li, Li
Long, Xingzhen
Chen, Qi
Sheng, Changcheng
Mei, Qian
Liu, Jue
Zhong, Shilong
Bai, Xue
Funding for this research was provided by:
the Science and Technology fund project of Health and Family Planning Commission of Guizhou province (gzwjkj2018-1-002)
National Natural Science Foundation of China (81960681)
2024 Drug Safety Research Project (ADR2024MS15)
Guizhou Provincial People’s Hospital 2019 National Natural Science Foundation of China post-subsidy fund (GPPH-NSFC-2019-26)
the Hospital Pharmacy Innovation Project for the youth established by Chinese Pharmaceutical Association and Servier (Tianjin) Pharmaceutical Co., Ltd. (CPA-B04-ZC-2024-001)
Article History
Received: 5 March 2025
Accepted: 5 August 2025
First Online: 25 August 2025
Declarations
:
: Ethical approval was obtained from the Ethics Committees of Guangdong Provincial People’s Hospital (no.2017071H) and Guizhou Provincial People’s Hospital (no. [2020]20).
: The study was conducted in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants.
: The authors declare no competing interests.